VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EMN 2018 | Advances in the classification of agressive myeloma

Nikhil Munshi, MD, of the Dana-Farber Cancer Institute, Boston, MA, discusses advances in the classification of high risk multiple myeloma (MM) from the 1st European Myeloma Network (EMN) Meeting, in Turin, Italy. He highlights improvements in our understanding of the biology of the disease, and how the resulting genetic knowledge impacts our stratification of aggresive MM.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter